291 related articles for article (PubMed ID: 31215389)
1. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
Vijayakumar EC; Bhatt LK; Prabhavalkar KS
Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
[TBL] [Abstract][Full Text] [Related]
2. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
Musumeci D; Roviello GN; Montesarchio D
Pharmacol Ther; 2014 Mar; 141(3):347-57. PubMed ID: 24220159
[TBL] [Abstract][Full Text] [Related]
3. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.
VanPatten S; Al-Abed Y
J Med Chem; 2018 Jun; 61(12):5093-5107. PubMed ID: 29268019
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 as biomarker and drug target.
Venereau E; De Leo F; Mezzapelle R; Careccia G; Musco G; Bianchi ME
Pharmacol Res; 2016 Sep; 111():534-544. PubMed ID: 27378565
[TBL] [Abstract][Full Text] [Related]
5. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
6. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Bae JS
Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 exacerbates CCl₄-induced acute liver injury in mice.
Chen M; Huang W; Wang C; Nie H; Li G; Sun T; Yang F; Zhang Y; Shu K; Wang C; Gong Q
Clin Immunol; 2014 Jul; 153(1):56-63. PubMed ID: 24726765
[TBL] [Abstract][Full Text] [Related]
8. HMGB-1 as a target for inflammation controlling.
Nogueira-Machado JA; de Oliveira Volpe CM
Recent Pat Endocr Metab Immune Drug Discov; 2012 Sep; 6(3):201-9. PubMed ID: 22845335
[TBL] [Abstract][Full Text] [Related]
9. HMGB1-directed drug discovery targeting cutaneous inflammatory dysregulation.
Lamore SD; Cabello CM; Wondrak GT
Curr Drug Metab; 2010 Mar; 11(3):250-65. PubMed ID: 20406187
[TBL] [Abstract][Full Text] [Related]
10. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis.
Chen Y; Sun W; Gao R; Su Y; Umehara H; Dong L; Gong F
Rheumatology (Oxford); 2013 Oct; 52(10):1739-47. PubMed ID: 23584368
[TBL] [Abstract][Full Text] [Related]
11. [Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].
Yao YM; Xu S; Sheng ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):459-65. PubMed ID: 19209785
[TBL] [Abstract][Full Text] [Related]
12. Extracellular HMGB1 as a proinflammatory cytokine.
Chen G; Ward MF; Sama AE; Wang H
J Interferon Cytokine Res; 2004 Jun; 24(6):329-33. PubMed ID: 15212706
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
14. High mobility group 1 B-box mediates activation of human endothelium.
Treutiger CJ; Mullins GE; Johansson AS; Rouhiainen A; Rauvala HM; Erlandsson-Harris H; Andersson U; Yang H; Tracey KJ; Andersson J; Palmblad JE
J Intern Med; 2003 Oct; 254(4):375-85. PubMed ID: 12974876
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 is a promising therapeutic target for acute liver failure.
Yamamoto T; Tajima Y
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):673-682. PubMed ID: 28657371
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 protein and its role in severe acute pancreatitis.
Shen X; Li WQ
World J Gastroenterol; 2015 Feb; 21(5):1424-35. PubMed ID: 25663762
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box-1 isoforms as potential therapeutic targets in sepsis.
Parrish W; Ulloa L
Methods Mol Biol; 2007; 361():145-62. PubMed ID: 17172710
[TBL] [Abstract][Full Text] [Related]
18. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury.
Xu W; Lu Y; Yao J; Li Z; Chen Z; Wang G; Jing H; Zhang X; Li M; Peng J; Tian X
Shock; 2014 Nov; 42(5):440-7. PubMed ID: 25004063
[TBL] [Abstract][Full Text] [Related]
19. Ketamine attenuates high mobility group box-1-induced inflammatory responses in endothelial cells.
Liu Z; Wang Z; Han G; Huang L; Jiang J; Li S
J Surg Res; 2016 Feb; 200(2):593-603. PubMed ID: 26453003
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
